Most research focuses on: Cosmetic appearance improvements Skin conditioning properties Laboratory and early-stage studies They are not medical treatments, and results depend on formulation, concentration, and product system
Competing interests KM has received research grants from Gilead Sciences, Merck, Janssen, and GSK/ViiV Healthcare and honoraria for Speakers Bureau and Advisory Boards from Gilead Sciences, Merck, Janssen and GSK/ViiV Healthcare
[PMID: 18380233] PubMed record related to this compound for laboratory literature review
When GHK binds with a copper ion (Cu2+), it forms the copper peptide GHK-Cu, the bioactive complex responsible for its profound regenerative effects
Zhou S, Liu J, Wan A, Zhang Y, Qi X
She reports consultancy fees from AstraZeneca, Boehringer Ingelheim, Bayer, Eli Lilly, Novo Nordisk, Travere Therapeutics Inc, ProKidney and Alnylam